African Union

CARB-X, AU release AMR guidance

CARB-X published compulsory guidance on Monday to ensure that new antibacterial products brought to market by its funded companies are used responsibly and made available to people in LMICs.

The Stewardship and Access Plan Development Guide—created by the Boston University-led nonprofit and its partners, including the Access to Medicine Foundation, the Gates Foundation, the Global Antibiotic Research and Development Partnership, the Global Antimicrobial Resistance Innovation Fund, and…

Mentions:
CARB-X, AMR, LMICs, access to medicines, BMGF, GARDP, GAMRIF, Wellcome Trust, African Union, drugs, vaccines, diagnostics
Read more
Covid-19 development round-up: January 15, 2021

The state of the hunt:

India inked vaccine supply deals with Bharat Biotech and SII.
  BioNTech upped its 2021 production target for Comirnaty to 2 billion doses—but the Pfizer/BioNTech vaccine faced near-term production slowdowns and delivery lags.
  An African Union-backed supply initiative locked up 270 million vaccine doses for the continent.

 

Vaccines


Approved or authorized vaccines

Sinovac’s inactivated jab notched its first…

Mentions:
Covid-19, vaccines, drugs, diagnostics, Sinovac, Butantan Institute, Lekhim, Moderna, Gamaleya Institute, Pfizer, BioNTech, BBIL, AstraZeneca, Janssen, J&J, IMCAS, Finlay Institute, Pasteur Institute, ExpreS2ion Biotech, SII, Oxford, Beximco Pharmaceuticals, Novavax, Precisa Medicamentos, EMA, Pharmaniaga, African Union, Afreximbank, Baxter Biopharma Solutions, Valneva, EU, CNBG, Sinopharm, WHO, COVAX AMC, COVAX, Gavi, halal, Regeneron, Lilly, BARDA, Gilead, Relief Therapeutics, Innovation Pharmaceuticals, FDA, NeuroRx, Alexion, Celltrion, Synairgen, GSK, Vir, Relay Medical, DiaSorin
Read more
Covid-19 development round-up: November 13, 2020

The state of the hunt:

With their mRNA vaccine showing an interim efficacy rate above 90%, Pfizer and BioNTech may have the necessary data to apply for U.S. FDA Emergency Use Authorization this month.
  Eli Lilly snagged the first FDA EUA for an anti-SARS-CoV-2 monoclonal antibody.
  Indonesia and Morocco laid out plans for Covid-19 mass immunization campaigns before year-end.

 

Vaccines


Phase 3 candidates:

Pfizer/BioNTech’s shot more…

Mentions:
Covid-19, vaccines, drugs, diagnostics, Pfizer, BioNTech, FDA, Lilly, WHO, Fosun, RDIF, Novavax, Zhifei, IMCAS, Anhui Zhifei Longcom, Chongqing Zhifei, Medicago, GSK, CNBG, SII, AstraZeneca, Moderna, BBIL, J&J, Janssen, Sinovac, CanSino, CureVac, Arcturus, Inovio, University of Queensland, Altimmune, Lonza, IISC, Mynvax, Sumagen, LG Chem, University of Nebraska-Lincoln, SSI, Medigen Vaccine Biologics, Capricor, RocketVax, Swiss Rockets, Gigabases Switzerland, Applied DNA Sciences, Takis, EC, CSL, Croda, Rhodiola, GL Rapha, COVAX AMC, Gavi, BMGF, ACT Accelerator, CEPI, UNICEF, PAHO, COVAX Facility, EMA, ESICM, Gilead, Zydus, Sagent, Nichi-Iko, Amgen, Eisai, Synairgen, Fujitsu, Kishida Chemical, PeptiDream, PeptiAID, Selva, MPP, Aurobindo, Beximco, Hetero, LumiraDx, African Union, Africa CDC, AMSP, CHAI, Adaptive, IHME
Read more
Subscribe to African Union